Jadenu 360 mg/1

Jadenu 360 mg is a film-coated tablet containing deferasirox, used for managing iron overload. This medication is commonly prescribed for conditions requiring iron chelation therapy.

Jadenu 360 mg is primarily used to treat iron overload in patients who have received multiple blood transfusions. Deferasirox, the active ingredient, helps to remove excess iron from the body. This medication is often prescribed for individuals with conditions like thalassemia or other disorders that require regular blood transfusions.

Common effects of Jadenu 360 mg may include nausea, vomiting, diarrhea, and abdominal pain. Some users might experience skin rash or changes in kidney function. It is important to monitor for any adverse reactions and consult a healthcare provider if they persist or worsen.

Jadenu 360 mg should be taken as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. Patients should be aware of potential side effects and inform their healthcare provider of any pre-existing conditions or medications they are taking.

Jadenu 360 mg may interact with certain medications, including those metabolized by the liver. It is advisable to avoid alcohol while taking this medication. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.